tiprankstipranks
Advertisement
Advertisement

CLNN Stock Latest News

Clene reports Q2 EPS ($1.08), consensus (26c)
The FlyClene reports Q2 EPS ($1.08), consensus (26c)
7d ago
CLNN
CLNN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CLNN Upcoming Earnings Report: What to Expect?
9d ago
CLNN
Buy Rating Reaffirmed on CNM-Au8 ALS Progress, Regulatory Momentum; $31 Price Target Maintained
PremiumRatings
Buy Rating Reaffirmed on CNM-Au8 ALS Progress, Regulatory Momentum; $31 Price Target Maintained
13d ago
CLNN
Clene Advances ALS Program with Biomarker NDA Update
PremiumCompany Announcements
Clene Advances ALS Program with Biomarker NDA Update
13d ago
8K
CLNN
Fourteen new option listings and one option delisting on July 22nd
PremiumThe Fly
Fourteen new option listings and one option delisting on July 22nd
1M ago
ACOG
ARTV
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials
PremiumTipRanks NewswireQuantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials
2M ago
SNY
BIIB
Clene Extends Note Maturities and Expands Equity Plan
Premium
Company Announcements
Clene Extends Note Maturities and Expands Equity Plan
3M ago
8K
CLNN
Roth says FDA approving Clene’s ALS treatment NDA a ‘long shot’
Premium
The Fly
Roth says FDA approving Clene’s ALS treatment NDA a ‘long shot’
3M ago
CLNN
Analyst Reiterates Buy on Advancing CNM-Au8 ALS Pathway and Funding Visibility; $31 Price Target Maintained
PremiumRatings
Analyst Reiterates Buy on Advancing CNM-Au8 ALS Pathway and Funding Visibility; $31 Price Target Maintained
3M ago
CLNN
Clene reports Q1 EPS (69c), consensus (70c)
PremiumThe Fly
Clene reports Q1 EPS (69c), consensus (70c)
3M ago
CLNN
Clene Extends Debt Maturities and Strengthens Cash Runway
PremiumCompany Announcements
Clene Extends Debt Maturities and Strengthens Cash Runway
3M ago
8K
CLNN
CLNN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CLNN Earnings this Week: How Will it Perform?
3M ago
CLNN
Clene price target raised to $50 from $48 at Canaccord
PremiumThe FlyClene price target raised to $50 from $48 at Canaccord
4M ago
CLNN
Clene Announces $7 Million Registered Direct Equity Offering
Premium
Company Announcements
Clene Announces $7 Million Registered Direct Equity Offering
4M ago
8K
CLNN
Clene provides update on NDA for ALS following Type C meeting with FDA
Premium
The Fly
Clene provides update on NDA for ALS following Type C meeting with FDA
4M ago
CLNN
Clene Advances CNM-Au8 Toward Accelerated ALS Approval
PremiumCompany Announcements
Clene Advances CNM-Au8 Toward Accelerated ALS Approval
4M ago
8K
CLNN
Clene, Lovesac, HDFC Bank, State Street, Vor Shock
PremiumWeekend Updates
Clene, Lovesac, HDFC Bank, State Street, Vor Shock
4M ago
HDB
STT
Surf Air, Cytokinetics, ASE, Itau, Clene Insider Shake-Up
PremiumWeekend Updates
Surf Air, Cytokinetics, ASE, Itau, Clene Insider Shake-Up
4M ago
ASX
CLNN
Insiders Cash Out: Cytokinetics, Itau, ASE, Clene, Black Stone
PremiumWeekend Updates
Insiders Cash Out: Cytokinetics, Itau, ASE, Clene, Black Stone
4M ago
ASX
BSM
Clene Secures Third-Year NIH Subaward for ALS Program
PremiumCompany AnnouncementsClene Secures Third-Year NIH Subaward for ALS Program
5M ago
8K
CLNN
Clene reports FY25 EPS ($2.65), consensus ($2.35)
Premium
The Fly
Clene reports FY25 EPS ($2.65), consensus ($2.35)
5M ago
CLNN
Clene outlines 2026 regulatory milestones and ALS strategy
Premium
Company Announcements
Clene outlines 2026 regulatory milestones and ALS strategy
6M ago
8K
CLNN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >